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Cardiovascular effects of aerobic exercise
training in formerly preeclamptic women
and healthy parous control subjects
Ralph R. Scholten, MD; Dick J. H. Thijssen, PhD; Fred K. Lotgering, PhD, MD;
Maria T. E. Hopman, PhD, MD; Marc E. A. Spaanderman, PhD, MD
OBJECTIVE: Women who have had preeclampsia demonstrate higher the control subjects, women who had had preeclampsia had
prevalence of metabolic syndrome (MetS), impaired vascular function,
and increased sympathetic activity and are at increased risk of car-
diovascular disease. The aim of this study was to assess the effects of
12 weeks of exercise training (70-80% maximum volume of oxygen
utilization) in women who had had preeclampsia on physical fitness,
components of MetS, vasculature, and autonomic functions compared
with healthy control subjects.
STUDY DESIGN: Our prospective case-control study included 24
normotensive women who had had preeclampsia and 20 control
subjects who were matched for age and postpartum interval (all 6-12
months after delivery). Before and after training, we measured all
components of MetS (ie, BP, lipids, glucose/insulin, and albuminuria),
carotid intima media thickness (IMT) and brachial and superficial
femoral artery endothelial function that used flow-mediated dilation
(FMD). Autonomic activity was quantified with power spectral analysis
(low-frequency/high-frequency power [LF/HF] ratio).
RESULTS: At baseline, women who had had preeclampsia demon-
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impaired endothelial function (FMD brachial artery, 5.3%  2.2% vs
10.8%  3.5%, respectively; FMD superficial femoral artery, 4.9%
 2.1% vs 8.7%  3.2%, respectively) and increased LF/HF power
ratio (2.2  1.0 vs 1.3  0.4, respectively; all P < .05). In both
groups, exercise training decreased values of most components of
MetS and IMT, improved FMD, and concurrently reduced LF/HF.
Despite these improvements, vascular and autonomic variables did
not normalize by 12 weeks of training in women who had had
preeclampsia.
CONCLUSION: This study demonstrates that exercise training in
women who had had preeclampsia and control subjects improves
components of MetS, endothelial function, vascular wall thickness,
and autonomic control. Nonetheless, trained women who had had
preeclampsia only reached a cardiovascular status that is comparable
with sedentary healthy control subjects.
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are prone to cardiovascular disease later
in life.1 The cardiovascular stress testof pregnancy therefore may unmask a
previously unrecognized cardiovascular
risk proﬁle in young women. Most likely
the development of preeclampsia duringg, and Spaanderman)
edical Center,
er, Maastricht
xercise Sciences,
.).
ls.gov/show/
1), Radboud University
Nijmegen, The
016/j.ajog.2014.04.025pregnancy reﬂects their preexisting,
often latent, cardiovascular risk condi-
tion.2,3 Alternatively, the increased risk
can be attributed to factors that originate
from the complicated pregnancy itself.4
In either case, women who have had
preeclampsia may beneﬁt from se-
lective screening for cardiovascular risk
markers,5 assuming that targeted treat-
ment alters these risk factors, and effec-
tively alter the risk for pregnancy-related
vascular complications and future car-
diovascular disease.
Women who have had preeclampsia
demonstrate higher prevalence of tra-
ditional cardiovascular risk factors (eg,
hypertension, dyslipidemia, and reduced
insulin sensitivity),3,6-8 endothelial
dysfunction,9-11 increased arterial wall
thickness,12 and augmented sympathetic
ajog.org Obstetrics Researchnervous system activity,13-15 compared
with healthy control subjects, which
likely relates to the increased cardiovas-
cular risks in these women. These dys-
functions potentially are amenable for
improvement by exercise training.16-18
Aerobic exercise training is a well-
established potent physiologic stimulus
that reduces primary and secondary
cardiovascular events.19 The beneﬁ-
cial effects of exercise on cardiovascular
risk are mediated not only through
improvement of traditional cardiovas-
cular risk factors20,21 but also through
up-regulation of nitric oxide (NO)e
derived endothelium-mediated vasodi-
lation,16,17,22 reduction of arterial wall
thickness,23 and reduction of sympa-
thetic tone.24,25 Although suggested in
many articles,26 no previous study has
examined the effects of exercise training
in women who have had preeclampsia
that could provide strong rationale for
advising exercise training in womenwith
increased cardiovascular risk.
This study therefore addressed the
question to what extent an exercise
training program (12 weeks of cycling at
70-80% maximum volume of oxygen
utilization [VO2max], 2-3 times per
week) in women who had had pre-
eclampsia affects physical ﬁtness, com-
ponents of the metabolic syndrome,
endothelial function, arterial wall thick-
ness, and autonomic function and how
these changes compare with control
subjects. The primary outcome of this
study was endothelial function, which
was measured by ﬂow-mediated dilation
(FMD). Endothelial dysfunction is not
only a key feature in preeclampsia, but
also it has proved to be associated with
cardiovascular disease burden and
outcome. We hypothesize that exercise
training improves vascular function and
structure as well as autonomic control,
we expect that these vascular and auto-
nomic changes to be related closely. The
question is, however, whether women
who have had preeclampsia will respond
adequately to the exercise stimulus, be-
cause these women maladapted to the
cardiovascular stimulus of previous
pregnancy. Based on the circulatory
maladaptation to previous pregnancy,
we hypothesized that women who havehad preeclampsia are less able to im-
prove vascular and autonomic charac-
teristics with exercise training compared
with healthy control subjects. We there-
fore performed an experimental inter-
vention study in 24 womenwho had had
preeclampsia and 20 control subjects.
MATERIALS AND METHODS
Subjects
We recruited 25 normotensive women
who had had preeclampsia and 22 con-
trol subjects. Primiparous women who
had had preeclampsia were recruited
from the Radboud University Nijmegen
Medical Centre, and control subjects
were recruited from the community by
advertisement at day care centers. Pre-
eclampsia in previous pregnancy was
deﬁned by the combination of gesta-
tional hypertension (140/90 mm Hg,
measured 2 and 6 hours apart) and
proteinuria (consistently 300 mg/24
hours) at >20 weeks of gestation in
previously normotensive women.27 In
our hospital, women who have had
preeclampsia are invited for cardiovas-
cular follow-up evaluation 6-12 months
after pregnancy that was complicated by
preeclampsia. At this follow-up visit,
women who were eligible for our study
were given written information about
this study, and if interested, these women
contacted our laboratory for further in-
formation and/or inclusion. Control
subjects contacted our laboratory after
reading the advertisement. If interested,
they received the same written infor-
mation as women who had had pre-
eclampsia. Control subjects were healthy
primiparous women whose pregnancy
charts were checked to ensure a normal
pregnancy course that resulted in a term
delivery. Participants were not compen-
sated in this study.
All participants were white women
who were healthy and normotensive at
the time of measurements. None of the
women had diabetes mellitus, autoim-
mune disease, or overt cardiovascular
disease. None of the women smoked or
used medication or supplements that
might affect the cardiovascular system.
None of the women who were included
were pregnant, breastfeeding, or using
hormonal contraceptives. Excluded fromNOVEMBER 2014 Amerianalysis were women who became preg-
nant during the course of the study and
women who were unable to cope with
physical exercise training. The study was
approved by the Medical Ethics Com-
mittee of the Radboud University Nij-
megen Medical Centre. All participants
gave written informed consent before
entering the study. The study adhered to
the principles of the Declaration of Hel-
sinki and was registered at clinicaltrials.
gov (id: NCT00900458).
Experimental design
Measurements and training were per-
formed in the nonpregnant state, 6-12
months after pregnancy. Subjects were
tested before and after 12 weeks of exer-
cise training. All measurements, except
VO2max, were performed during the
same visit. VO2max was tested 1-5 days
from the other visit. In sequential
order, we measured body characteristics
(weight, height, waist circumference),
metabolic components (lipids, glucose,
and insulin concentrations), blood pres-
sure (BP), heart rate (HR), autonomic
function by spectral analysis of sponta-
neous ﬂuctuations in HR and BP
and vascular ultrasound measurements,
intima media thickness (IMT), ﬂow-
mediated dilation (FMD) and vasodila-
tion response to glyceryl trinitrate (GTN).
Experimental procedures
Tests andmeasurements were performed
between days 3 and 11 of the menstrual
cycle to minimize possible endocrine
inﬂuences of the sex hormones on
the cardiovascular and autonomic ner-
vous system. All measurements, except
VO2max were performed after an over-
night fast. Participants were instructed to
abstain from strenuous physical activity
in the 24 hours before testing. Partici-
pants collected urine in the 24 hours
preceding the measurements. The 24-
hour urine sample was assayed for al-
bumin, protein, and creatinine to deﬁne
microalbuminuria corrected for creati-
nine output (g/mol creatinine) and total
protein level (g/24 hours; Aeroset;
Abbott Laboratories, Green Oaks, IL).
Height, body mass (888 scale; Seca,
Hamburg, Germany), and waist circum-
ference were measured. Venous bloodcan Journal of Obstetrics& Gynecology 516.e2
Research Obstetrics ajog.orgsamples were taken from the antecubital
vein and analyzed for metabolic param-
eters: glucose, insulin, total cholesterol,
high- and low-density lipoproteins, and
triglycerides (Aeroset; Abbott Labora-
tories). The homeostasis model assess-
ment index was calculated as fasting
insulin to estimate insulin resistance:
fasting insulin (mU/L)  fasting glucose
(mmol/L)/22.5.28
Tests were performed under stan-
dardized conditions in a temperature-
controlled room (22  0.5C).
Measurements were performed at the
same time in the morning to prevent
diurnal variation in the vascular and
autonomic responses.29 After 30minutes
rest in the supine position, BP and HR
were measured oscillometrically (Dina-
map, Vital Signs Monitor 1846; Critikon
Inc, Tampa, FL), at the right upper arm,
with the cuff size recommended for the
arm circumference, at 3-minute in-
tervals for 30 minutes. We recorded
systolic (SAP), diastolic (DAP), and
mean (MAP) arterial pressures and HR
(beats/min) and used the median values
of 9 consecutive measurements for
analysis. This restingHRwas used for the
calculation of the training intensity.
Autonomic function
Autonomic function was measured with
subjects comfortably lying in supine
position in a quiet, partially darkened
room. Autonomic activity and barore-
ﬂex sensitivity (BRS) were quantiﬁed by
spectral analysis, from a 5-minute
recording of spontaneous ﬂuctuations
in HR and BP.30 HR and arterial BP were
measured continuously using a ﬁnger
arterial BPemonitoring device attached
to the third digit of the right hand at a
sampling rate of 100Hz (Finometer;
Finapres Medical Systems BV, Amster-
dam, The Netherlands). Post hoc, these
recordings were subdivided into data
segments of 100s that overlapped for
50% and resampled at 5.12 Hz. Each
segment was then analyzed with fast
Fourier transformation to search for
rhythmic ﬂuctuations in SAP and pulse
interval with a frequency range between
0 and 2.56 Hz. The amplitude of each
ﬂuctuation determines the power at
each frequency. The ratio of absolute516.e3 American Journal of Obstetrics& Gynecollow-frequency (LF) and high-frequency
(HF) powers of the pulse interval was
used to represent the autonomic balance
between the sympathetic and vagal sys-
tem. The LF component is regarded a
marker of mainly sympathetic modula-
tion; HF components mainly reﬂect
vagal activity. Therefore, a higher LF/HF
ratio can be interpreted as a sign of
increased sympathetic dominance. Bar-
oreﬂex sensitivity (milliseconds/millime-
ters of Mercury) was deﬁned as the LF
transfer gain from SAP to pulse interval,
which provides information about the
changes in the HR (output) in response
to ﬂuctuation in SAP (input).
Vascular measurements
Allmeasurementswere performed by the
same sonographer (R.R.S.) according to
recent guidelines for assessment of the
FMD29 who used a 10-MHz multifre-
quency linear array probe attached to a
high resolution ultrasound machine
(T3000; Terason Corporation, Burling-
ton, MA). Ultrasound parameters were
set to optimize longitudinal B-mode
images of the lumen/arterial wall inter-
face. Continuous Doppler velocity was
assessed simultaneously with the use of
the lowest possible insonation angle (al-
ways<60 degrees). For assessment of the
FMD responses, a rapid inﬂation/deﬂa-
tion pneumatic cuff (Hokanson, Belle-
vue, WA) was positioned distal to the
imaged artery and inﬂated for 5 minutes
(220mmHg) to provide the stimulus for
reactive hyperemia. FMD represents a
predominantly NO-mediated, endothe-
lium-dependent vasodilation.
Carotid artery intima media thick-
ness. The intima media thickness (IMT)
of the left common carotid artery (CA)
was measured 2 cm proximal to the
bulbus. Perpendicular incidence of the
B-mode imaging ultrasound beam in
relation to the orientation of the vessel
provided clearly demarcated intima
medial boundaries, which were opti-
mized with the use of contrast control
subjects. Wall thickness and diameter
were measured continuously for 1 min-
ute. The measurement was repeated
once from a different perpendicular
plane (90 degree, compared withogy NOVEMBER 2014previous measurement). From the 2
measurements, mean diameter and wall
thickness were calculated and used for
analysis.31
Brachial artery FMD. Brachial artery
(BA) FMD was measured with subjects
positioned supine with the right arm
extended and immobilized with foam,
supported at an angle of approximately
80 degrees from the torso. The pneumatic
cuff was placed distal to the olecranon.
The BA was scanned 2-5 cm above the
antecubital fossa. Before inﬂation, resting
baseline diameter and blood ﬂow velocity
were recorded continuously for at least
1 minute. After cuff deﬂation, diameter
and blood ﬂow velocity were recorded
continuously for 3 minutes.
Superﬁcial femoral artery FMD. Su-
perﬁcial femoral artery (SFA) FMD was
measured with subjects positioned su-
pine with the lower leg slightly elevated
(approximately 10 degrees). The pneu-
matic cuff was placed 15 cm below the
inguinal ligament. The SFAwas scanned
in the proximal one-third of the thigh, at
least 5 cm distal from the bifurcation
and above the cuff position. Before
inﬂation, resting baseline diameter and
blood ﬂow velocity were recorded con-
tinuously for at least 1 minute. After cuff
deﬂation, diameter and blood ﬂow ve-
locity were recorded continuously for
5 minutes.
Vasodilation after GTN. GTN responses
were measured after a resting period of
30 minutes to allow arterial diameter to
return to baseline, another 1-minute
baseline recording of the SFA was
made. Endothelium-independent dila-
tion was examined with the use of a
single sublingual dose of GTN (400 mg;
G-Pohl-Boskamp GmbH and Co KG,
Hohenlockstedt, Germany), a NO
donor, followed by 10 minutes of
recording of the arterial diameter. The
maximal dilation after administration
of GTN represents the endothelium-
independent vasodilation.
Conduit artery diameter, wall
thickness, and blood ﬂow analysis
Posttest analysis of diameter, velocity,
and wall thickness of the 3 conduit
ajog.org Obstetrics Researcharteries (CA, BA, and SFA) was
performed with edge-detection and wall-
tracking Digital Imaging and Commu-
nications in Medicineebased software32
(National Electrical Manufacturers As-
sociation, Rosslyn, VA) to minimize
investigator bias.29,32 The post-hoc
analysis of the diameter, velocity, and
wall thickness was performed blinded
(to subject and moment of assessment).
FMD was calculated as the percentage of
rise in peak diameter from the preceding
baseline diameter. The postdeﬂation
shear rate data, which was derived from
simultaneously acquired velocity and
diameter measures at 30 Hz, was used to
calculate the area under the shear rate
curve for data up to the point of maximal
postdeﬂation diameter (FMD) for each
measurement. Reproducibility of the BA
FMD using this semiautomated software
processes a coefﬁcient of variance of
6.7%32; the SFA FMD has a coefﬁcient of
variance of 15%.29
Physical ﬁtness
Physical ﬁtness was measured before and
after a 12-week training program. Fitness
was deﬁned as the peak oxygen uptake
(VO2max: milliliter minute
e1 kilo-
grame1) during a maximal cycling test
on a cycle ergometer (Excalibur Sport;
Lode BV, Groningen, The Netherlands).
Tests were performed in the afternoon
after a light lunch. The initial workload
set at 10 W for 1 minute followed by
10-W increments every minute until
complete exhaustion. Breath-by-breath
oxygen uptake was measured with spi-
roergometric equipment (Quark CPET,
Cosmed, Milan, Italy). HR and rhythm
were continuously recorded by 3-lead
echocardiography. Maximal workload
(workmax) was deﬁned as the last
completed work load before exhaustion.
Test performance was considered to be
adequate when (1) the increase in VO2
(milliliters) during workmax was <150
mL compared with the previous work-
load, indicating plateau formation in
oxygen uptake; (2) HR at workmax was
<10 beats/min from estimated maxi-
mal HR (220-age); (3) the respiratory
exchange ratio (CO2/O2) was consis-
tently >1.1 during workmax, and (4)
capillary lactate level was >8 mmol/L 90seconds after exhaustion. If the test
failed to achieve these 4 qualiﬁcations,
the test was repeated 2-3 days later. In
3 cases (2 women who had had pre-
eclampsia, 1 control subject), the test
had to be repeated; all tests were even-
tually considered adequate.
Exercise training
Exercise training consisted of 12 weeks of
HR-controlled cycle training (cycle
ergometer; Corival; Lode BV) at 70-80%
of VO2max for 2-3 times per week (ac-
cording to the most recent American
College of Sports Medicine guideline).33
Participants trained twice a week during
the ﬁrst 6 weeks and 3 times a week
during the last 6 weeks. Each training
session was supervised and was executed
in the gymnasium of our laboratory.
Participants were instructed not to ex-
ercise in addition to the exercise proto-
col that they were given. During each
training session, HR was monitored
continuously and recorded (RS800CX;
Polar Electro Inc, New York, NY). Each
training session started with a 10-minute
warm-up at 50% of the HR reserve
(HRR) above the resting HR. HRR was
calculated in the following manner:
HRR¼HRmaxeHRrest, in which HRmax
is the maximal HR measured during the
ﬁtness test at study entry and HRrest is
the HR determined at rest. Training
consisted of 40 minutes of cycling at
70-80% of the individual HR reserve
above the resting HR.Within their target
HR zone, participants were free to
choose the number of revolutions per
minute. The training was completed by
cooling down for 5 minutes at warm-up
workload.
Statistics
Statistical analyses were performed with
SPSS software (version 17.0; SPSS Inc,
Chicago, IL). All data are reported as
mean  SD, unless stated otherwise.
Normality of data was tested with
Kolmogorov-Smirnov tests. Statistical
signiﬁcance was assumed at a probability
value of < .05. Two-way repeated-mea-
sures analysis of variance was used to
examine differences between women
who had had preeclampsia and control
subjects (groups) to assess the effects ofNOVEMBER 2014 Ameritraining (intervention) and to determine
whether the training effects differed
between patients and control subjects
(groups  intervention interaction).
Post-hoc Bonferroni analysis was used to
correct for multiple comparisons. Pear-
son correlation coefﬁcient was used to
examine the relation between exercise-
induced change in autonomic function
(LF/HF ratio) and endothelial function
(FMD) in both groups. Based on an
anticipated difference in %FMD (which
has a coefﬁcient of variation of 6.7-
10.5%32) between women who had had
preeclampsia and control subjects of
4%, a power of the study of 90%, and an
alpha level of .05, we needed 17 subjects
per individual group. We based our
group-size calculation for the interven-
tion part of our study on an anticipated
change in %FMD (primary outcome
measure) of 2%, a power of 90%, and an
alpha level of .05. Based on these as-
sumptions, we required 18 subjects per
group. To anticipate possible drop outs,
we decided to include at least 20 subjects
per group.
RESULTS
Included in the analysis were 24 women
who had had preeclampsia and 20
control subjects, after exclusion of 1
woman who had had preeclampsia
(who became pregnant) and 2 control
subjects (1 woman who became preg-
nant and 1 woman who did not ﬁnish
the training). Mean age (32  4 vs 32 
4 years, respectively; P ¼ .62) and
postpartum interval (7  2 vs 7  1
months, respectively; P ¼ .88) were
comparable between groups. Women
who had had preeclampsia delivered at
an earlier gestational age compared with
control subjects (32 [range, 29e37] vs
40 [range, 38e41] weeks of gestation,
respectively; P < .01) and delivered
children with a lower birthweight
compared with control subjects (1571
675 vs 3532  311 g, respectively).
Baseline values
Before training, physical ﬁtness was
similar in both groups (VO2max: control
subjects, 28.2  3.7 mL mine1 kge1;
patients, 27.0  4.0 mL mine1 kge1,
respectively; P¼ .32), as were body masscan Journal of Obstetrics& Gynecology 516.e4
TABLE 1
Characteristics before and after exercise training of healthy control subjects (n[ 20) and women who had had preeclampsia (n[ 24)
Variables
Healthy control subjects (mean ± SD)
Women who had had preeclampsia
(mean ± SD) 2-way analysis of variance (P value)
Before training After training Before training After training Groupa Interventionb
Group X
interventionc
Body mass index, kg/m2 26.8  3.4 25.1  6.8 25.9  4.9 24.4  7.0 .63 .04 .88
Waist circumference, cm 93  10 91  10 92  12 89  11 .84 < .01 .25
Arterial pressure
Systolic, mm Hg 109  6 104  6 119  10d 112  8 < .01 < .01 .39
Diastolic, mm Hg 66  6 63  6 74  7d 69  7 < .01 < .01 .19
Mean, mm Hg 78  5 74  5 86  8d 80  7 < .01 < .01 .26
Resting heart rate, beats/min 63  9.8 57  7.6 77  8.7d 59  8.9 .15 < .01 .03
Biochemical parameters
Fasting glucose, mmol/L 4.7  0.5 4.6  0.5 4.8  0.5 4.7  0.5 .51 .01 .32
Fasting insulin, mmol/L 7.7  6.9 5.9  4.3 13.3  9.3d 8.4  5.0 .04 < .01 .04
Homeostatic model assessment
of insulin resistance index
1.7  1.8 1.3  1.1 3.0  2.3d 1.8  1.1 .04 < .01 .04
Total cholesterol, mmol/L 4.5  0.9 4.1  0.8 4.6  1.0 4.5  1.1 .45 < .01 .14
High density lipoprotein
cholesterol, mmol/L
1.2  0.3 1.3  0.3 1.1  0.2 1.2  0.2 .19 < .01 .88
Low density lipoprotein
cholesterol, mmol/L
2.8  0.8 2.5  0.7 2.8  0.8 2.7  0.8 .58 < .01 .58
Triglycerides, mmol/L 0.8  0.4 0.8  0.3 1.4  0.9d 1.1  0.5d .02 .18 .19
Albuminuria, mg/mmoL creatinine 0.4  0.3 0.4  0.3 2.4  4.4d 1.7  3.0d .04 .07 .08
Physical fitness
VO2max, mL min
e1 kge1 28.2  3.7 31.9  3.5 27.0  4.0 30.4  5 .32 < .01 .52
Maximal heart rate, beats/min 186  9 185  7 189  7 189  6 .08 .57 .32
Maximal ventilation, L/min 96  20 108  10 88  19 99  18 .07 < .01 .74
Maximal work load, W 195  27 210  22 188  25 204  27 .27 < .01 .53
a Patients vs control subjects; b Main effect exercise program; c Interaction between groups and exercise training; d P < .05 compared with control subjects before training (t-test).
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TABLE 2
Vascular characteristics before and after exercise training of healthy control subjects (n[ 20) and women who had had preeclampsia (n[ 24)
Variables
Healthy control subjects (mean ± SD)
Women who had had preeclampsia
(mean ± SD) 2-way analysis of variance (P value)
Before training After training Before training After training Groupa Interventionb
Group X
interventionc
Carotid artery
Resting diameter, mm 5.6  0.5 5.6  0.5 5.7  0.6 5.6  0.4 .98 .99 .74
Intima media thickness, mm 477  65 423  65 580  92d 530  138 < .01 < .01 .86
Wall-to-lumen ratio 0.086  0.012 0.076  0.012 0.104  0.02d 0.095  0.025 < .01 < .01 .86
Brachial artery
Diameter at baseline, mm 2.8  0.3 3.0  0.3 3.0  0.3 3.1  0.3 .15 <.01 .10
Flow-mediated dilation, % 11.8  3.5 13.3  3.6 5.3  2.2d 8.1  2.7d < .01 < .01 .58
Shear rate area under
the curve, 103 sece1
27.9  10.4 27.1  12.7 26.3  11.2 24.3  13.1 .44 .41 .93
Time to peak diameter, sec 48  15 51  13 50  14 59  20 .26 .08 .43
Superficial femoral artery
Diameter at baseline, mm 5.6  0.7 5.8  0.6 5.7  0.7 5.7  0.7 .90 .81 .84
Flow-mediated dilation, % 8.7  3.2 10.5  2.8 4.9  2.1d 6.1  2.2d < .01 < .01 .98
Shear rate area under
the curve, 103 sece1
14.5  9.1 14.7  5.5 15.8  10.5 14.4  9.1 .82 .53 .69
Time to peak diameter, sec 83  36 74  27 85  36 78  38 .62 .08 .88
Glyceryl trinitrate, % 11.9  4.0 13.0  3 10.9  3.3 12.1  2.1 .24 .04 .75
a Patients vs control subjects; b Main effect exercise program; c Interaction between groups and exercise training; d P < .05 compared with control subjects before training (t-test).
Scholten. Cardiovascular effects of exercise training in formerly preeclamptic women. Am J Obstet Gynecol 2014.
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TABLE 3
Autonomic characteristics before and after exercise training of healthy control subjects (n[ 20) and women
who had had preeclampsia (n[ 24)
Heart rate variability
analysis
Healthy control subjects
(mean ± SD)
Women who had had
preeclampsia (mean ± SD)
2-way analysis of variance
(P value)
Before training After training Before training After training Groupa Interventionb
Group X
interventionc
Low frequency power, msec2 1005  329 911  315 1455  526d 1106  442 < .01 .07 .27
High frequency power, msec2 806  259 965  369 768  276 789  294 .04 .19 .41
Low/high frequency ratio 1.3  0.4 1.0  0.3 2.2  1.0d 1.5  0.6d < .01 < .01 .51
Baroreceptor sensitivity,
msec  mm Hge1
17.6  5.7 22.1  7.9 8.5  3.6d 12.5  5.1d < .01 < .01 .86
a Patients vs control subjects; b Main effect exercise program; c Interaction between groups and exercise training; d P < .05 compared with control subjects before training (t-test).
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Research Obstetrics ajog.orgindex, resting HR, and fasting glucose
and cholesterol concentrations (Table 1).
In women who had had preeclampsia,
group average values of SAP, DAP, MAP,
fasting insulin and triglyceride concen-
trations, and albuminuria were higher
than in control subjects. Vascular di-
ameters (CA, BA, and SFA) were not
different between groups. In women
who had had preeclampsia, CA-IMTwas
larger and BA- and SFA-FMD responses
were smaller than in control subjects
(Table 2). Mean shear rate area under the
curve, time-to-peak of FMD, and vaso-
dilation in response to GTN were not
different between groups. In women
who had had preeclampsia, the average
LF/HF ratio was higher and BRS was
lower than in control subjects (Table 3).
Effects of training
Twelve weeks of training improved
physical ﬁtness in both groups to the
same extent, because VO2max increased
by 14%  8% in control subjects and
13%  7% in patients who had had
preeclampsia (Table 1). Training re-
duced HRrest, SAP, DAP, MAP, body
mass index, waist circumference and
fasting glucose, insulin, total cholesterol,
and low-density lipoprotein cholesterol
concentrations in women who had
had preeclampsia and control sub-
jects, although it increased high-density
lipoprotein cholesterol concentrations.
The reduction in HRrest and fasting in-
sulin concentration was 14% and 13%,
respectively, which was more in women516.e7 American Journal of Obstetrics& Gynecolwho had had preeclampsia than in con-
trol subjects. Training abolished dif-
ferences in BP and insulin resistance
between women who had had pre-
eclampsia and control subjects. Albu-
minuria and triglyceride concentration
remained higher in womenwho had had
preeclampsia than in control subjects
after training (Table 1). Training reduced
CA-IMT and increased BA- and SFA-
FMD responses in women who had had
preeclampsia and control subjects to a
similar extent (Figure 1), which indi-
cated improved endothelial function.
Yet, values did not normalize in women
who had had preeclampsia. Training did
not affect shear rate area under the
curve, time-to-peak of FMD, or vasodi-
latation in response to GTN in either
group (Table 2). Training reduced LF/HF
ratios and increased BRS to a similar
extent in both groups. Sympathetic
dominance and the reduced BRS did not
normalize in women who had had pre-
eclampsia and remained elevated signif-
icantly compared with trained control
subjects (Table 3).Correlations
Training similarly improved autonomic
functioning (delta LF/HF) and endo-
thelial function (delta FMD) in women
who had had preeclampsia and control
subjects. Training induced changes in
sympathetic dominance and endothelial
function correlate inversely in both BA
and SFA (Figure 2).ogy NOVEMBER 2014COMMENT
The cardiovascular and autonomic ef-
fects of aerobic training in women who
have had preeclampsia have not been
studied previously. This study demon-
strates that women who have had pre-
eclampsia and healthy parous control
subjects can improve their cardiovascular
risk proﬁle with 12 weeks of exercise
training. The improvement of compo-
nents of the metabolic syndrome in both
groups suggests reduced biochemical
vascular stress. The cardioprotective ef-
fects of training in women who have had
preeclampsia and healthy women after
delivery are further supported by the
improved endothelial function (BA- and
SFA- FMD), vascular structure (CA-
IMT), and autonomic function (LF/HF
and BRS). Despite these improvements,
exercise training did not normalize
vascular and autonomic variables in
women who had had preeclampsia. In-
terestingly, we found that exercise in-
duced vascular improvements that were
correlated with training-induced changes
in autonomic functioning in both
healthy control subjects and women who
had had preeclampsia.
In our study, baseline physical ﬁtness
was not different between women who
had had preeclampsia and control sub-
jects. Our baseline data were similar to
those of previous cross-sectional studies
that reported increased prevalence of
traditional cardiovascular risk fac-
tors,6,8,33,34 vascular dysfunction,9-11,35
increased vascular wall thickness,12 and
FIGURE 1
Effect of exercise training
The effect of exercise training on healthy control subjects (n ¼ 20) and women who had had
preeclampsia (n ¼ 24) before (black bars) and after (grey bars) 12 weeks of exercise training:
A, carotid artery intima media thickness (CA, IMT); B, brachial artery flow-mediated dilation
(BA, FMD); C, superficial femoral artery flow-mediated dilation (SFA, FMD). Error bars represent
SE; the asterisk denotes the t-test for women who had had preeclampsia compared with control
subjects before training (P < .05).
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NOVEMBER 2014 Ameriincreased sympathetic activity13 in
women who had had preeclampsia
compared with control subjects. The
comparable GTN responses between
groups are in agreement with previous
studies that suggested endothelial dys-
function, rather than vascular smooth
muscle cell dysfunction, in women who
had had preeclampsia.9,29 Our study adds
the novel observation that endothelial
dysfunction in women who have had
preeclampsia represents a systemic pro-
cess because endothelial function was
impaired in both BA an SFA and because
the arterial wall was thickened in yet
another vascular bed (CA). Another
novel observation was the correlation
between endothelial dysfunction and
sympathetic dominance. High sympa-
thetic outﬂow in conjunction with
endothelial dysfunction is thought to
have synergistic and detrimental effects
on cardiovascular risk.36 Particularly in-
teresting is the potential of the detection
of these risk proﬁles inwomen at an early
enough stage to beneﬁt from low-cost
interventions such as modiﬁcation of
lifestyle.
The training program (12 weeks of
cycling at 70-80% VO2max for 2-3 times
per week) increased VO2max to the
same extent in both groups. The im-
provement of physical ﬁtness was within
the expected range.37 Training improved
most traditional cardiovascular risk fac-
tors to the same extent in women who
had had preeclampsia and control sub-
jects. HRrest and homeostasis model
assessment index reductions were more
pronounced in women who had had
preeclampsia than in control subjects.
Most likely this reﬂects the higher base-
line values in women who had had pre-
eclampsia. The beneﬁcial effects of
exercise training cannot be explained by
changes in traditional cardiovascular
risk factors alone,17 but also by direct
effects on vasculature and autonomic
nervous system. In our study, vascular
and autonomic variables improved
similarly in both groups. The effects in
all studied arteries suggest a systemic
effect of exercise training on the vascu-
lature. Studies have demonstrated that
exercise-induced changes in shear stress
provide the principal physiologiccan Journal of Obstetrics& Gynecology 516.e8
FIGURE 2
Correlation between exercise-
induced changes in LF/HF ratio
and changes in FMD%
A, Brachial artery (BA) and B, superficial femoral
artery (SFA) in response to 12 weeks of exercise
training in healthy control subjects (n¼ 20) and
women who had had preeclampsia (n ¼ 24).
The dashed line represents the regression line of
control subjects; the thick black line represents
the regression line of women who had had
preeclampsia. R represents the Pearson corre-
lation coefficient.
FMD%, flow-mediated dilation; LF/HF, low-frequency/high-
frequency power.
Scholten. Cardiovascular effects of exercise training in
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Research Obstetrics ajog.orgstimulus to adaptation in vascular func-
tion and structure, likely by enhancing
NO bioavailability38 and by effects on
other angiogenic factors (eg, endothelin-
1,39 angiotensin-2, vascular endothelial
growth factor, and oxidative stress).40
The change in FMD with training
correlated inversely with the change in
LF/HF in both groups (Figure 2). This is
in line with cross-sectional studies in
healthy men that have shown that tonic
elevation in sympathetic nerve activity is
associated with increased IMT41 and
reduced FMD.42 These data suggest not
only that FMD reﬂects NO-mediated516.e9 American Journal of Obstetrics& Gynecolendothelial vasodilation but also that
FMD is also affected by alterations in
sympathetic activity.
We did not observe a difference in
baseline VO2max between women who
had had preeclampsia and control sub-
jects. This may originate from unin-
tended selection of control subjects with
relatively poor VO2max who were
recruited by newspaper advertisement.
Women with subjectively poor ﬁtness
may have had an incentive to participate
in the study, knowing that their cardio-
vascular health would be assessed and
improved by training. However, despite
the similar VO2max, age, and body mass
index between women who had had
preeclampsia and control subjects,
comparisons between groups indicate
signiﬁcant differences in metabolic, cir-
culatory, and autonomic proﬁles be-
tween groups. This observation suggests
that these differences in circulatory and
metabolic proﬁles do not originate from
differences in a priori physical ﬁtness
levels. The women who had had pre-
eclampsia in our study were referred to
our tertiary center. This may have led to
over representation of more severely
complicated pregnancies, which ex-
plained the median gestational age of
32 weeks. Care should be taken therefore
to extrapolate our ﬁndings to the gen-
eral formerly preeclamptic population
(including women who experienced
preeclampsia at term). In a previous
study, we demonstrated that the preva-
lence of cardiovascular risk factors
increase with an earlier onset of pre-
eclampsia.43 It is conceivable that the
baseline differences between women
who have had preeclampsia and control
subjects are limited to a particularly high
risk set of women.
Another potential limitation is that
participants were studied 6-12 months
after delivery. Even though >80% of
recovery takes place within 6 months,
recovery may have been incomplete.44 If
one would assume that recovery in our
study was only 80%, later testing at
higher baseline ﬁtness with the same
training programmost likely would have
resulted in smaller training effects.
Because the postpartum interval was
similar for both groups, it is unlikely thatogy NOVEMBER 2014the postpartum interval has affected the
comparisons between women who had
had preeclampsia and control subjects in
our study.
Women who have had preeclampsia
are at increased cardiovascular risk.
The risk of a cardiovascular event after
preeclampsia is estimated to be 2-fold
compared with women who had nor-
motensive pregnancies. Because the risk
of a cardiovascular event increases with
age, absolute risk at 60-69 years would be
14.2% and 30.7%, respectively, for
women without and with a history of
preeclampsia, which suggests that a
woman who had preeclampsia might
become eligible for primary prevention
at an earlier age.1 We observed that
training markedly improved indicators
of cardiovascular health in women who
had had preeclampsia, which suggests
reduction in the risk of recurrent pre-
eclampsia and cardiovascular disease in
later life. Our rigorous and supervised
training program (12 weeks of cycling at
70% VO2max, 2-3 times per week) was
unable to normalize vascular and auto-
nomic variables in women who had had
preeclampsia. One might argue that
12 weeks of training is not long enough
for women who have had preeclampsia
to achieve full normalization of cardio-
vascular and metabolic functions. Our
study is at least the proof of the princi-
ple that the cardiovascular risk proﬁle
in women who have had preeclampsia
is amenable to lifestyle interventions.
At any rate, our data support the re-
commendation of exercise training in
women after delivery, especially in
women with a history of preeclampsia.
Future studies will have to evaluate
whether a longer duration of exercise
training and less supervised or different
types of exercise training (resistance
training, combined aerobic þ resistance
training) equally or evenmore effectively
reduce cardiovascular risks and whether
exercise training may improve future
pregnancy outcomes in women with a
history of preeclampsia. Based on ob-
servations in other populations, but with
longer training programs, it is likely that
women who have had preeclampsia can
continue to improve their cardiovascular
risk proﬁle with longer training.45 This
ajog.org Obstetrics Researchidea is supported by the general lack of
interaction effects in our study, which
suggests a similar response to the exer-
cise stimulus between women who have
had preeclampsia and control subjects.
Exercise training in women who
have had preeclampsia signiﬁcantly im-
proves traditional cardiovascular risk
factors, endothelial function, vascular
wall thickness, and autonomic balance.
Nonetheless, after 12 weeks of training,
women who had had preeclampsia only
reached a vascular and autonomic status
that was comparable with sedentary
control subjects, which stresses the re-
commendation of prolonged exercise
training in young women with a latent
cardiovascular risk proﬁle that is un-
masked by their hypertensive pregnancy
course. -
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